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Abstract: Ferroptosis is a form of programmed cell death that is characterized by lipid peroxidation 
and is inducible by iron and the accumulation of reactive oxygen species (ROS). It is triggered by 
erastin but inhibited by antioxidants such as -tocopherol, -carotene, polyphenols, and iron 
chelators such as deferoxamine (DFO), nitrilotriacetic acid (NTA), and ethylenediaminetetraacetic 
acid (EDTA). This study investigated the protective effects of two polyphenols, curcumin and (−)- 
epigallocatechin-3-gallate (EGCG), against iron loading and erastin-mediated ferroptosis in MIN6 
cells. Cells were treated with polyphenols before exposure to iron-induced oxidative stress 
comprising of 20 μmol/L of 8-hydroxyquinoline (8HQ) and 50 μmol/L of ferric ammonium citrate, 
(FAC) (8HQ+FAC) or Fenton reaction substrate (FS) (30 μmol/L of FeSO4 and 0.5 of mmol/L H2O2) 
and 20 μmol/L erastin. Cell viability was determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyltetrazolium bromide (MTT) assay, iron levels were measured by inductively-coupled 
plasma mass spectrometry (ICP-MS), glutathione and lipid peroxidation were assayed with 
commercially-available kits. Curcumin and EGCG both significantly protected pancreatic cells 
against iron-induced oxidative damage. Moreover, both compounds also protected against erastin-
induced ferroptosis in pancreatic cells. The polyphenols enhanced cell viability in erastin-treated 
MIN6 cells in a dose- and time-dependent manner. Furthermore, MIN6 cells exposed to erastin 
alone showed elevated levels of iron, glutathione (GSH) depletion, glutathione peroxidase 4 (GPX4) 
degradation and lipid peroxidation (p < 0.05) compared to cells that were protected by pre-treatment 
with curcumin or EGCG. Taken together, the data identify curcumin and EGCG as novel ferroptosis 
inhibitors, which might exert their protective effects by acting as iron chelators and preventing GSH 
depletion, GPX4 inactivation, and lipid peroxidation in MIN6 cells. The implications of the findings 
on the effects of iron overload and ferroptosis represent a potential therapeutic strategy against iron-
related diseases. 
Keywords: curcumin; (-)-epigallocatechin-gallate; iron; ferroptosis 
 
1. Introduction 
Iron is a vital trace metal in physiological processes such as oxygen transport, respiration, energy 
generation and DNA synthesis, and is a structural component of numerous enzymes and proteins in 
the body. The ability of iron to perform these functions relies on its existence in variable and 
interconvertible oxidation states. Iron can exchange single electrons with metabolites to generate 
reactive oxygen species (ROS) that are capable of causing DNA damage, protein denaturation, and 
lipid peroxidation [1]. Together, these events have recently been defined as a form of programmed 
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cell death called ferroptosis [2]. Excessive ROS production is neutralized by a repertoire of defence 
antioxidants enzymes such as superoxide dismutase, catalase, and glutathione peroxidases (GPXs) 
[3]. Dysregulation of iron homeostasis can lead to iron-overload disorders such as hemochromatosis 
and thalassemia, which are characterized by elevated levels of ROS. It is noteworthy that there is a 
high prevalence of type 2 diabetes mellitus (T2D) amongst patients [4], and epidemiological studies 
have reported significant associations between excess iron stores and T2D [5,6]. Toxicity of iron in 
pancreatic β-cells, possibly because of elevated ROS, results in decreased insulin synthesis and 
secretion [6]. Iron overload-mediated oxidative stress causes impaired insulin signalling and 
inhibition of ATP production due to mitochondrial dysfunction [6,7]. Furthermore, reduced 
antioxidant levels in conjunction with increased free radical production have been reported to cause 
pancreatic β-cell damage [8,9]. 
Although synthetic iron chelators such as deferoxamine (DFO), nitrilotriacetic acid (NTA) and 
ethylenediaminetetraacetic acid (EDTA) are used in treating secondary iron overload disorders, in 
particular natural plant products or bioactive compounds of plant origin such as polyphenols are 
emerging as potent and efficacious alternatives [10,11]. Moreover, in addition to their iron chelating 
properties, some polyphenols also possess antioxidant potential [12]. Polyphenols such as curcumin 
and (−)- epigallocatechin-3-gallate (EGCG) have been shown to form complexes readily with different 
metal ions [12,13]. 
Ferroptosis emerged recently as a phenomenon that encapsulates the interplay of iron 
accumulation, excessive ROS levels and lipid peroxidation, and culminates in cell death that is 
associated with degenerative disorders [14]. In light of this, the current study investigated the 
protective functions of polyphenols against iron toxicity and erastin-induced ferroptosis in murine 
MIN6 cells. In essence, the investigation was designed to demonstrate the inhibition of erastin-
induced ferroptosis, iron accumulation, and lipid peroxidation by curcumin and EGCG inclusion in 
treated MIN6 pancreatic cells. 
2. Results 
2.1. The Protective Effects of Polyphenols on Iron-Induced Oxidative Stress 
Initial experiments investigated the sensitivity of MIN6 pancreatic cells to iron-induced stress 
and the protective effects of polyphenolic compounds. In cells pre-incubated with six different 
polyphenols before exposure to FS and 8HQ+FAC for 2 h, only curcumin and EGCG showed 
significant protection against iron-induced cell damage (Figure 1A, B). 
2.2. Protective Function of Curcumin and EGCG against Ferroptosis 
Having identified curcumin and EGCG as the most potent polyphenols for conferring protection 
against iron-induced stress, we next investigated the potential of these compounds to act as inhibitors 
of ferroptosis. Subsequently curcumin and EGCG were compared with quercetin, rutin, tannic acid 
and phytic acid as inhibitors of erastin-induced ferroptosis in MIN6 cells. Of the six compounds that 
were tested, curcumin and EGCG exhibited the best protection against erastin-induced cell death in 
MIN6 cells (Figure 1C). 
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Figure 1. Protective effects of different polyphenols against iron-mediated toxicity and ferroptosis. 
MIN6 cells were treated with 20 μM curcumin, quercetin, rutin, EGCG, tannic acid or phytic acid for 
24 h and supplemented with (A) Fenton Substrates (FS), (B) 8HQ+FAC for 2 h and (C) MIN6 cells 
were treated overnight with 20 μM erastin, in the absence or presence of quercetin, rutin, curcumin, 
tannic acid, phytic acid and EGCG. The percentage of cell viability is relative to control cell samples. 
Curcumin and EGCG inhibited erastin-induced cell death in a dose-dependent manner. Curcumin 
and EGCG had a protective effect against ferroptosis at 20 μM in MIN6 for 24 h, with a valuable 
statistical difference between erastin and cell treated with erastin + 20 μM curcumin or EGCG. All the 
values are expressed with the mean ± SEM, n = 8. #p < 0.05 control vs. treatment groups, **p < 0.01 and 
****p < 0.0001 compared with FS and 8HQ+FAC group only. (C) #p < 0.05 control vs. treatment groups, 
****p < 0.0001 vs. erastin only. One-way ANOVA, Tukey post-hoc test. 
2.3. Dose-Response Effects of Curcumin and EGCG against Erastin-Induced Ferroptosis  
Cell viability was evaluated in cells exposed to a range of EGCG and curcumin concentrations 
in the presence of erastin for 24 h. Curcumin caused a decrease in cell mortality in a dose-dependent 
manner, over a concentration range of 5–20 μM in MIN6 cells (Figure 2A). Likewise, EGCG also 
inhibited erastin-induced cell death in a dose-dependent manner in MIN6 cells (Figure 2B).  
2.4. Time Course Effects of Curcumin and EGCG against Erastin-Induced Ferroptosis 
Next, we determined the temporal range of protection conferred by curcumin or EGCG against 
erastin-induced ferroptosis. Protection was evident with both curcumin and EGCG in MIN6 cells 
after 24 h. Over these specific time points, both polyphenols provided a similar pattern of protection 
against erastin-induced cell death in MIN6 cells (Figure 2C, D).  
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Figure 2. Anti-ferroptosis activity of curcumin and EGCG in MIN6 cells. Cells were treated overnight 
with 20 μM erastin in the absence or presence of curcumin or EGCG. The percentage of cell viability 
is relative to control cell samples. Curcumin and EGCG inhibited erastin-induced cell death in a dose-
dependent manner. Curcumin (A) and EGCG (B) had a protective effect against ferroptosis at 20 μM 
in MIN6 for 24 h, with valuable statistical difference between erastin and cell treated with erastin + 20 
μM curcumin or EGCG. Curcumin (C) and EGCG (D) inhibited erastin-induced cell death in a time-
dependent manner in MIN6 with valuable statistical difference between erastin and cell treated with 
erastin + 20 μM curcumin or EGCG. All the values are expressed with the mean ± SEM, n = 8, #p < 0.05 
control vs. treatment groups, *p < 0.05 and ****p < 0.0001 vs. erastin only. One-way ANOVA, Tukey 
post-hoc test. 
2.5. Curcumin and EGCG Limit Iron Accumulation and Lipid Peroxidation in Ferroptosis 
As iron accumulation is a known cause of ferroptotic cell death [14], we next investigated 
whether curcumin and EGCG would suppress iron accumulation resulting from erastin treatment in 
MIN6 cells. Intracellular iron level in MIN6 cells following exposure to erastin was 225% greater than 
in untreated control cells (Figure 3A). Treatment with curcumin or EGCG resulted in a decrease in 
erastin-induced iron accumulation in MIN6 cells. In parallel, the effect of erastin on the lipid 
peroxidation marker malondialdehyde (MDA) was measured. MDA levels were increased 
significantly following treatment with erastin, but were suppressed by co-exposure to curcumin and 
EGCG (Figure 3B). 
Pharmaceuticals 2019, 12, 26 5 of 11 
 
 
Figure 3. Curcumin and EGCG suppress iron and lipid accumulation in pancreatic cells. (A) Cells 
were treated overnight with 20 μM erastin in the absence or presence of curcumin or EGCG. 
Percentage of Fe2+ is relative to control cell samples. Curcumin and EGCG decreased erastin-induced 
iron accumulation at 20 μM in MIN6 for 24 h, with significant statistical difference between erastin 
and cell treated with erastin + 20 μM curcumin or EGCG. (B) Percentage of MDA is relative to control 
cell samples. Curcumin and EGCG decreased erastin-induced lipid peroxidation at 20 μM in MIN6 
for 24 h, with valuable statistical difference between erastin and cell treated with erastin + 20 μM 
curcumin or EGCG. All the values are expressed with the mean ± SEM, n = 3, #p < 0.05 control vs. 
treatment groups, **p < 0.01 and ****p < 0.0001 vs. erastin only. One-way ANOVA, Tukey post-hoc test. 
2.6. Curcumin and EGCG Decrease Glutathione (GSH) Depletion and Glutathione Peroxidase 4 (GPX4) 
Degradation 
GSH level was reduced in MIN6 cells exposed to erastin and co-treatment of cells with curcumin 
or EGCG significantly abrogated GSH decline (Figure 4A). Moreover, treatment of MIN6 cells with 
erastin also resulted in decreased GPX4 protein levels (Figure 4B, C), and curcumin significantly 
inhibited this response in the cells. 




Figure 4. Curcumin and EGCG inhibit GSH depletion in pancreatic cells. Cells were treated overnight 
with 20 μM erastin in the absence or presence of curcumin or EGCG. Percentage GSH level is relative 
to control cell samples. (A) Curcumin and EGCG decreased erastin-induced GSH level. (B) Western 
blot analysis showed that curcumin alone significantly suppressed erastin-induced GPX4 level in 
MIN6 for 24 h. (C) Densitometry of Western blots GPX4 protein bands of GPX4. All the values are 
expressed with the mean ± SEM, n = 3, # p < 0.05 control vs. treatment groups, *p < 0.05 and **p < 0.01 
vs. erastin only. One-way ANOVA, Tukey post-hoc test. 
3. Discussion 
Polyphenols offer beneficial pharmaceutical and medicinal properties [15,16] in addressing a 
range of ailments and disorders [16]. However, much remains unknown regarding the mechanisms 
of action of most polyphenolic compounds. In addition, the specific effects of therapeutic flavonoids 
need to be investigated [16]. Pancreatic cells are extremely susceptible to oxidative stress due to the 
production of high levels of endogenous ROS and a low expression of anti-oxidative enzymes [17]. 
The current study investigated the protective effects of different polyphenols on iron overload 
in a pancreatic β-cell model. The effects of iron stressors (Fenton Substrate and 8HQ+FAC, iron 
loading) on MIN6 cell viability were tested in vitro. FS and 8HQ+FAC exerted pronounced toxicity in 
the cultured cells. However, both curcumin and EGCG showed protective effects against iron-
induced toxicity (Figure 1A, B). This is in agreement with the protection conferred by curcumin in 
brain cells cultured from Alzheimer’s patients, where curcumin inhibited cell death and decreased 
ROS production [18]. Moreover, Mandel et al. [19] showed a notable decrease in lipid peroxidation 
and oxidative modifications of membranes in neural cortex and hippocampal cells after exposure to 
epicatechin. The mechanisms underlying the prevention of damage by ROS and iron with curcumin 
and EGCG are unclear, but could involve binding of iron, prevention of redox cycling by iron, and 
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quenching of free radicals formed by iron [20,21]. These properties could contribute to effective 
neutralisation of iron toxicity.  
The mechanisms of action of EGCG and curcumin are complex and likely to be multifaceted. 
Curcumin and EGCG are likely to modulate expression and activity of proteins of iron metabolism, 
suggesting that these polyphenols have abilities of an iron chelator [21,22]. Under conditions of iron 
deprivation, iron regulatory proteins (IRPs) are activated to repress ferritin and stabilise transferrin 
receptor 1 mRNA (TfR1). Activation of IRPs, translational repression of ferritin, and induction of TfR1 
serve as indicators of reduced intracellular iron and are observed in cells treated with iron chelators. 
Both activated IRPs and TfR1 increased in response to curcumin in mice [23]. 
Furthermore, curcumin or EGCG co-treatment reversed cell death triggered by 20 μM erastin 
that was evident at 24, 48, and 72 h (Figure 2). The polyphenols also suppressed iron accumulation 
that was mediated by erastin treatment in pancreatic cells (Figure 3A), corroborating previous 
findings which demonstrated that baicalein decreased iron levels in PANC1 and BxPc3 cells against 
erastin-induced ferroptosis [24]. Moreover, Dixon et al. [25] showed that DFO and ferrostatin-1, 
potent inhibitors of ferroptosis, prevented iron accumulation and iron dependent-ROS production in 
breast cancer cells.  
Lipid peroxidation is one of the critical signalling events that characterize ferroptosis [25]. There 
is a strong relationship between iron and lipid peroxidation, as iron is known to cause ROS generation 
in ferroptosis [26]. Accordingly, it has been suggested that iron chelators and polyphenols might play 
a protective role against lipid peroxidation [24,25]. The study also demonstrated that both curcumin 
and EGCG exerted a decrease in MDA accumulation in pancreatic cells treated with erastin (Figure 
3B). Xie et al. [24] showed that baicalein inhibited lipid peroxidation in pancreatic cancer cells treated 
with erastin. Furthermore, L6 skeletal muscle cells treated with EGCG and docosahexaenoic acid 
(DHA) exhibited lower ROS production, and lower MDA levels, than cells treated with DHA alone 
[27]. Together, these studies suggest that polyphenolic compounds by acting as ROS scavengers can 
limit lipid peroxidation of cellular membranes. Compelling evidence shows that when repair 
mechanisms such as antioxidant defence enzymes are overwhelmed, cell death in response to iron 
accumulation and lipid peroxidation becomes unavoidable.  
Reduced GSH is an essential intracellular antioxidant with a vital role in the protection of lipids 
and DNA from ROS [25]. In ferroptosis, erastin treatment leads to inhibition of system Xc−, which is 
the oxidative stress-inducible cysteine-glutamate exchange system, thus causing the inhibition of 
GSH biosynthesis [28,29]. Curcumin is known to induce phase II antioxidants enzymes such as 
glutathione reductase, glutathione-S-transferase, glutathione peroxidase, NAD(P)H: quinone 
oxidoreductase-1, and thioredoxin reductase [22]. It is shown in this study that erastin-induced GSH 
depletion was ameliorated by curcumin and EGCG in MIN6 cells (Figure 4A). This in turn could 
potentially influence the antioxidant activity of glutathione peroxidase 4 (GPX4), apart from the 
direct suppression of its protein level by erastin (Figure 4C) [29].  
In agreement with the current study, breast cancer cells treated with erastin caused GSH 
depletion, which inactivated GPX enzymes and induced ferroptosis [30]. Interestingly, -tocopherol 
complemented GPX4 deficiency and prevented cell death in GPX4 knockout mice [31]. In essence, 
GPX4 is one of the most important membrane protective enzymes [31]. Erastin-induced GPX4 
degradation in neurons and T cells accelerated lipid peroxidation and ferroptotic cell death [32]. GSH 
levels decreased in the same study, but not to the level of statistical significance [32]. Consequently, 
erastin could bind directly to GPX4 to reduce its enzymatic activity, or indirectly reduce the level of 
glutathione in the cells [25,26]. 
The results of this study revealed that (i) curcumin or EGCG treatment reversed the cell death 
triggered by erastin, (ii) curcumin and EGCG ameliorated erastin-induced iron accumulation, (iii) the 
levels of lipid peroxidation in MIN6 cells were decreased by treatment with curcumin or EGCG, and 
(iv) curcumin and EGCG attenuated erastin-induced decrease in GSH and GPX4 protein levels in the 
cells. The study shows that curcumin and EGCG are inhibitors of ferroptosis in cultured MIN6 
pancreatic β-cells and may protect against iron-induced oxidative damage in iron-overload disorders.  
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4. Materials and Methods 
4.1. Chemicals and Reagents 
The antibodies to GPX4 and β-actin were obtained from R&D systems (Abingdon, UK) and 
Thermo Scientific (Dartford, UK) respectively. Curcumin, quercetin, rutin, EGCG, tannic acid and 
phytic acid were obtained from Sigma-Aldrich Company Ltd. (Dorset, UK) (curcumin cat. no. C7727; 
EGCG cat. no. E3768). Erastin was purchased from Bertin Bioreagent (Montigny-le-Bretonneux, 
France). 
4.2. Cell Culture 
The mouse MIN6 pancreatic β-cell line was used in this study [33]. The cells (< 30 passages) were 
routinely cultured in T25-cm2 plastic flasks. MIN6 cells were maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing 15% heat-inactivated fetal bovine serum (FBS), 100 U/mL 
penicillin, and 0.1 mg/mL streptomycin. Cells were kept at 37 °C under a humidified atmosphere 
containing 5% CO2. The medium was changed twice a week. Cells were used for experimentation or 
split when 80–90% confluent. 
4.3. Cell Viability Assay  
Protective effects of different polyphenols against iron-induced cell death were investigated in 
MIN6 cells. Cellular metabolic activity was measured using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyltetrazolium bromide (MTT) assay in a 96-well plate. MIN6 cells were seeded at a density of 
5 × 104 cells per well and pre-treated with 20 μM curcumin, quercetin, rutin, EGCG, tannic acid or 
phytic acid overnight, before exposure to either FS or 8HQ+FAC for 2 h. Moreover, the protective 
function of the polyphenols against erastin-induced ferroptosis was studied. Following this, 100 μL 
of fresh DMEM along with 10 μL of MTT solution (5 mg/mL in sterile phosphate buffer saline) was 
added to each well. After incubating for 3 h at 37 °C, 100 μL of a solubilisation buffer, dimethyl 
sulfoxide (DMSO) was added and incubated for 15 minutes at room temperature. To determine MTT 
reaction in the cells, optical density was read in a microplate reader (Bio-Tek ELx800) at 490 nm. Cell 
viability was expressed as a percentage of the controls [34]. 
4.4. Fenton Reaction Oxidative Stress 
Optimal Fenton reaction substrate (FS) was developed and validated as 30 μmol/L FeSO4 and 
0.5 mmol/L H2O2 [35]. Cells were pre-incubated with 20 μM curcumin, quercetin, rutin, EGCG, tannic 
acid or phytic acid for 24 h before exposure to FS for 2 h, to investigate the protective effect of the 
polyphenols against oxidative stress. Afterwards, cell viability was quantified using the MTT assay. 
4.5. Iron-Induced Stress on Pancreatic Cells 
Cells were pre-treated with various compounds before exposure to rapid iron overload damage 
[36] with 50 μmol/L FAC and 20 μmol/L 8HQ (8HQ+FAC). Cells were incubated for a further 2 h at 
37 °C to allow rapid iron uptake. Afterwards, cell viability was determined with the MTT assay. 
4.6. Cellular iron levels 
Inductively-coupled plasma mass spectrometry (ICP-MS) analysis of total iron level was 
performed. Cell pellets collected for metal analysis by ICP-MS were re-suspended in 200 μL of 50 
mM NaOH. Concentrated 68% HNO3 (nitric acid) was added to the samples and they were then 
heated for 3 h at 80 °C to complete the digestion. Measurements were made using an Agilent ICP-MS 
7700 x series ICP-MS instrument under operating conditions suitable for routine multi-element 
analysis. 
 
4.7. Lipid Peroxidation Assay 
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The concentration of malondialdehyde (MDA)—one of end products of lipid peroxidation—was 
assessed using the lipid peroxidation colorimetric assay kit purchased from Cohesion Biosciences 
(Slough, UK) according to the manufacturer’s instructions.  
4.8. Glutathione Assay  
The GSH concentration in cell lysates was assessed by using a glutathione assay kit purchased 
from Sigma Aldrich (Dorset, UK) according to the manufacturer’s instructions.  
4.9. Western Blot  
MIN6 cells were lysed with RIPA Buffer (Tris/Cl (pH 7.6); 100 mmol/L, EDTA; 5 mmol/L, NaCl; 
50 mmol/L, β-glycerophosphate; 50 mmol/L, NaF; 50 mmol/L, Na3VO4; 0.1 mmol/L, NP-40; Sodium 
deoxycholate; 0.5%), supplemented with Protease Inhibitor Cocktails (Thermo Scientific, Dartford, 
UK). Protein concentration was determined using Bio-Rad reagents (Bio-Rad Laboratories, Hercules, 
CA, USA). Twenty micrograms (20 μg) of protein extracts were loaded onto a 12% gel in SDS 
polyacrylamide gels (SDS-PAGE). The resolved proteins were transferred onto PVDF membranes 
and blocked with 5% non-fat dry milk in TBST buffer (20 mM Tris–Base, pH 7.4, 500 mM NaCl, 0.1% 
Tween20). The membranes were probed with primary GPX4 antibody (R&D systems, Abingdon, UK) 
and a β-actin secondary antibody (Thermo Scientific, Dartford, UK) diluted in TBST and incubated 
overnight at 4 °C. Afterwards, the membranes were probed with HRP-conjugated secondary 
antibody (diluted 1:5000, R&D Systems, Abingdon, UK) for 1 h at room temperature. Cross-reactivity 
was observed with peroxidase-linked anti-IgG by using Clarity Western ECL Substrate (Watford, 
UK). Densitometry of the band intensities were determined using Image J software (National Institute 
of Health, USA). 
4.10. Statistical Analysis  
All statistical analyses were performed using GraphPad Prism 7 (USA). Data are presented as 
mean ± SEM. A one-way ANOVA was used to test differences between the treatments. Comparisons 
between the experimental groups were conducted with Tukey’s post hoc analysis, as appropriate. 
Differences were considered significant at p < 0·05.  
Author Contributions: T.K. performed the experiments and wrote the manuscript, M.V.A. performed 
experiments, P.A.S. co-supervised the work and co-edited the manuscript, G.O.L-D. conceptualized and 
supervised the work, and wrote and edited the manuscript. 
Funding: This research received no external funding. Tugba Kose receives financial sponsorship and a 
scholarship from the Turkish Government Ministry of National Education. Mayra Vera-Aviles is sponsored by 
the Mexican Government (CONACYT). 
Acknowledgements: The authors thank Mohamad Aslam for assistance with ICP-MS and Palsa Kondaiah for 
technical support.  
Conflicts of Interest: The authors declare that they have no conflicts of interest with the contents of this article. 
References 
1. Kang, R.; Tang, D. Autophagy and ferroptosis—What is the connection? Curr. Pathobiol. Rep. 2017, 5, 153–
159. 
2. Yu, X.; Long, Y.C. Crosstalk between cystine and glutathione is critical for the regulation of amino acid 
signaling pathways and ferroptosis. Sci. Rep. 2016, 6, 30033. 
3. Latunde-Dada, G.O. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy. Biochim. Biophys. Acta 
Gen. Subj. 2017, 8, 1893–1900. 
4. Rajpathak, S.N.; Crandall, J.P.; Wylie-Rosett, J.; Kabat, G.C.; Rohan, T.E.; Hu, F.B. The role of iron in type 2 
diabetes in humans. Biochim. Biophys. Acta Gen. Subj. 2009, 1790, 671–681. 
Pharmaceuticals 2019, 12, 26 10 of 11 
 
5. Sun, L.; Zong, G.; Pan, A.; Ye, X.; Li, H.; Yu, Z.; Zhao, Y.; Zou, S.; Yu, D.; Jin, Q.; Hu, FB. Elevated plasma 
ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. 
J. Nutr. 2013, 143, 1459-1465. 
6. Basuli, D.; Stevens, R.G.; Torti, F.M.; Torti, S.V. Epidemiological associations between iron and 
cardiovascular disease and diabetes. Front. Pharmacol. 2014, 5, 117. 
7. Silva, M.; Freitas Bonomo, L.; Paula Oliveira, R.; Lima, W.G.; Silva, M.E.; Pedrosa, M.L. Effects of the 
interaction of diabetes and iron supplementation on hepatic and pancreatic tissues, oxidative stress 
markers, and liver peroxisome proliferator-activated receptor-α expression. J. Clin. Biochem. Nutr. 2011, 49, 
102–108. 
8. Rahimi-Madiseh, M.; Malekpour-Tehrani, A.; Bahmani, M.; Rafieian-Kopaei, M. The research and 
development on the antioxidants in prevention of diabetic complications. Asian Pacific Journal of Tropical 
Medicine 2016, 9(9), 825-831. 
9. Hmidene, A.B.; Hanaki, M.; Murakami, K.; Irie, K.; Isoda, H., Shigemori, H. Inhibitory activities of 
antioxidant flavonoids from tamarix gallica on amyloid aggregation related to alzheimer’s and type 2 
diabetes diseases. Biol. Pharm. Bull. 2017, 40, 238–241. 
10. Coskun, O.; Kanter, M.; Korkmaz, A.; Oter, S. Quercetin, a flavonoid antioxidant, prevents and protects 
streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol. Res. 2005, 51, 117–
123. 
11. Martín, M.Á.; Fernández-Millán, E.; Ramos, S.; Bravo, L.; Goya, L. Cocoa flavonoid epicatechin protects 
pancreatic beta cell viability and function against oxidative stress. Mol. Nutr. Food Res. 2014 58, 447-456. 
12. Jiao, Y.; Wilkinson, J.; Pietsch, E.C.; Buss, J.L.; Wang, W.; Planalp, R.; Torti, F.M.; Torti, S.V. Iron chelation 
in the biological activity of curcumin. Free Radic. Biol. Med. 2006, 40, 1152–1160. 
13. Messner, D.J.; Sivam, G.; Kowdley, K.V. Curcumin reduces the toxic effects of iron loading in rat liver 
epithelial cells. Liver Int. 2009, 29, 63–72. 
14. Bertrand, R.L. Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously 
during ferroptosis and are mutually amplifying events. Med. Hypotheses 2017, 101, 69–74.  
15. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative 
Medicine and Cellular Longevity 2009, 2(5), 270-278. 
16. Zhang, H.; Tsao, R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory 
effects. Current Opinion in Food Science 2016, 8, 33-42. 
17. Rashidi, A.; Kirkwood, T.B.; Shanley, D.P. On the surprising weakness of pancreatic beta-cell antioxidant 
defences: An evolutionary perspective. In Evolutionary Biology; Springer: Berlin/Heidelberg, Germany, 
2009; pp.109–125, ISBN 978-3-642-00952-5. 
18. Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin has potent anti-amyloidogenic effects for 
Alzheimer’s β-amyloid fibrils in vitro. J. Neurosci. Res. 2004, 75, 742–750. 
19. Mandel, S.; Amit, T.; Bar-Am, O.; Youdim, M.B. Iron dysregulation in alzheimer’s disease: Multimodal 
brain permeable iron chelating drugs, possessing neuroprotective-neuro rescue and amyloid precursor 
protein-processing regulatory activities as therapeutic agents. Prog. Neurobiol. 2007, 82, 348–360. 
20. Dairam, A.; Fogel, R.; Daya, S.; Limson, J.L. Antioxidant and iron-binding properties of curcumin, 
capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. Journal of Agricultural and 
Food Chemistry 2008, 56(9), 3350-3356. 
21. Reznichenko, L.; Amit, T.; Zheng, H.; Avramovich-Tirosh, Y.; Youdim, M.B.H.; Weinreb, O.; Mandel, S. 
Reduction of iron-regulated amyloid precursor protein and β-amyloid peptide by (–)-epigallocatechin-3-
gallate in cell cultures: implications for iron chelation in Alzheimer's disease. Journal of Neurochemistry 
2006, 97(2), 527-536. 
22. Badria, F.A.; Ibrahim, A.S.; Badria, A.F.; Elmarakby, A.A. Curcumin attenuates iron accumulation and 
oxidative stress in the liver and spleen of chronic iron-overloaded rats. PLoS One 2015, 10, e0134156. 
23. Wang, J.; Pantopoulos, K. Regulation of cellular iron metabolism. Biochem. J. 2011, 434, 365–381. 
24. Xie, Y.; Song, X.; Sun, X.; Huang, J.; Zhong, M.; Lotze, M.T.; Zeh, H.J.; Kang, R.; Tang, D. Identification of 
baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 
2016, 473 (4), 775–780. 
25. Dixon, S.J.; Lemberg, K.M.; Lamprecht, M.R.; Skouta, R.; Zaitsev, E.M.; Gleason, C.E.; Patel, D.N.; Bauer, 
A.J.; Cantley, A.M.; Yang, W.S.; et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 
2012, 149, 1060–1072. 
Pharmaceuticals 2019, 12, 26 11 of 11 
 
26. Cao, J.Y.; Dixon, S.J. Mechanisms of ferroptosis. Cell. Mol. Life Sci. 2016, 73 (11-12), 2195–2209. 
27. Casanova, E.; Baselga-Escudero, L.; Ribas-Latre, A.; Arola-Arnal, A.; Bladé, C.; Arola, L.; Salvadó, M.J. 
Epigallocatechin gallate counteracts oxidative stress in docosahexaenoxic acid-treated myocytes. Biochim. 
Biophys. Acta-Bioenerg. 2014, 1837, 783–791. 
28. Gaschler, M.M.; Stockwell, B.R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 2017, 482 
(3), 419–425. 
29. Yang, W.S.; SriRamaratnam, R.; Welsch, M.E.; Shimada, K.; Skouta, R.; Viswanathan, V.S.; Cheah, J.H.; 
Clemons, P.A.; Shamji, A.F.; Clish, C.B.; et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014, 
156 (1-2), 317–331. 
30. Yang, W.S.; Stockwell, B.R. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol. 2016, 26 (3), 165–176. 
31. Seiler, A.; Schneider, M.; Förster, H.; Roth, S.; Wirth, E.K.; Culmsee, C.; Plesnila, N.; Kremmer, E.; Rådmark, 
O.; Wurst, W.; Bornkamm, G.W. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-
lipoxygenase dependent-and AIF-mediated cell death. Cell Metabolism 2008, 8(3), 237-248. 
32. Angeli, J.P.; Schneider, M.; Proneth, B.; Tyurina, Y.Y.; Tyurin, V.A.; Hammond, V.J.; Herbach, N.; Aichler, 
M.; Walch, A.; Eggenhofer, E.; et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal 
failure in mice. Nat. Cell Biol. 2014, 16 (12), 1180–1191. 
33. Miyazaki, J.I.; Araki, K.; Yamato, E.; Ikegami, H.; Asano, T.; Shibasaki, Y.; Oka, Y.; Yamamura, K.I. 
Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: Special reference 
to expression of glucose transporter isoforms. Endocrinology 1990, 127 (1), 126–132. 
34. Zhang, S.; Ntasis, E.; Kabtni, S.; Van den born, J.; Navis, G.; Bakker, S.J.; Krämer, B.K.; Yard, B.A.; Hauske, 
S.J. Hyperglycemia does not affect iron mediated toxicity of cultured endothelial and renal tubular 
epithelial cells: Influence of L-carnosine. J. Diabetes Res. 2016, 8710432. doi:10.1155/2016/8710432. 
35. Karbownik-Lewińska, M.; Stępniak, J.; Lewiński, A. High level of oxidized nucleosides in thyroid 
mitochondrial DNA; damaging effects of Fenton reaction substrates. J. Diabetes Res. 2012, 5, 24–32. 
36. Messner, D.J.; Rhieu, B.H.; Kowdley, K.V. Iron overload causes oxidative stress and impaired insulin 
signaling in AML-12 hepatocytes. Dig. Dis. Sci. 2013, 58 (7), 1899–18908. 
 
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
